New Generics and Biosimilars = New Risks for Confusion
December 2025
More patients will be admitted on new generics or biosimilars...and you’ll need to watch for potential confusion or problems.
Generic liraglutide (Saxenda) is the first generic GLP-1 agonist for obesity. But don’t expect this daily injectable to be added to formulary. The generic still costs about $40/day versus $45/day for the brand.
On med histories, document the generic and brand name...PLUS the indication...to avoid confusion between different liraglutide products or the patient’s medical conditions.
Practical advice for a better career, with unlimited access to CE
Hospital Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote